BioNexus Gene Lab Corp share price logo

BioNexus Gene Lab Corp

NASDAQ: BGLC

$1.50

-0.07

(-4.46%)

as on

BioNexus Gene Lab Corp Stock Performance

as on September 22, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $1.47
    $1.53
    downward going graph

    2.00%

    Downside

    2.00%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.07
    $6.10
    downward going graph

    28.67%

    Downside

    306.67%

    Upside

    downward going graph

BioNexus Gene Lab Corp share price movements today

Previous Close
$1.57
Open
$1.53
Volume
361.9K
Market Cap
$4.6M
Day's Low - High
$1.47 - $1.53
52 Week Low - High
$1.07 - $6.10

BioNexus Gene Lab Corp Historical Returns

1 Month Return
-1.26 %
3 Month Return
-39.85 %
1 Year Return
-70.76 %
3 Year Return
-83.81 %
5 Year Return
0 %

BioNexus Gene Lab Corp Stock Fundamentals & Key Indicators

Check BioNexus Gene Lab Corp market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.6M

EPS (TTM)

-1.26

Dividend Yield

0.00%

PE Ratio (TTM)

-1.25

Industry PE ratio

-4.33

PEG Ratio

-0.113454067551617

Return On Equity TTM

-32.91%

BioNexus Gene Lab Corp Stock Valuation

Track how BioNexus Gene Lab Corp P/E has moved over time to understand its valuation trends.

BioNexus Gene Lab Corp in the last 5 years

  • Overview

  • Trends

Lowest (-461.48x)

December 31, 2022

Industry (-4.33x)

December 31, 2025

Today (-2.45x)

December 31, 2025

Highest (485.43x)

December 31, 2021

LowHigh

Today’s Price to Earnings Ratio: -2.45x

BioNexus Gene Lab Corp vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of BioNexus Gene Lab Corp with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BioNexus Gene Lab Corp image
BioNexus Gene Lab Corp
NA$4.6MNA-1.2511.64%0.00%
Novonesis image
Novonesis
NA$30.6BNA40.7854.89%0.24%
Ecolab image
Ecolab
StrongBuy$77.0B24.43%36.6144.11%1.07%
Sherwin-Williams Company image
Sherwin-Williams Company
Buy$77.9B10.46%29.2949.07%0.99%
Linde image
Linde
StrongBuy$213.4B48.22%29.4745.64%1.36%
See all

Stock Returns calculator for BioNexus Gene Lab Corp Stock including INR - Dollar returns

The BioNexus Gene Lab Corp stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

BioNexus Gene Lab Corp investment value today

Current value as on today

₹30,306

Returns

-₹69,694

(-69.69%)

Returns from BioNexus Gene Lab Corp Stock

-₹72,067 (-72.07%)

Dollar Impact

₹2,373 (+2.37%)

Indian Investors' Interest in BioNexus Gene Lab Corp Stock

Search interest for BioNexus Gene Lab Corp Stock has increased by 53% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:53% versus previous 30 day period

BioNexus Gene Lab Corp Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
2
1
2
2
2
2
2
0
0
0
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
0
0
-1
0
0
0
0
-1
0
0
EBITDA
0
0
-1
0
0
0
0
0
0
0
Interest Expense
0
0
0
0
0
0
-
0
0
-
Depreciation
0
0
0
0
0
0
0
0
0
-
Income Before Tax
0
0
-1
0
0
0
0
-1
0
0
Income Tax Expense
0
0
0
0
-
-
-
-
-
-
Net Income
0
0
-1
0
0
0
0
-1
0
0
Net Profit Margin
15.33%
14.62%
12.41%
12.25%
16.07%
16.28%
14.85%
-0.82%
-99.51%
17.05%

BioNexus Gene Lab Corp Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
0
0
11
13
10
9
9
7
Gross Profit
0
0
0
1
2
1
1
1
1
Operating Income
0
0
0
1
1
0
-2
-1
-3
EBITDA
0
0
0
1
1
0
-2
-1
-2
Interest Expense
-
-
-
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
0
0
0
1
1
0
-2
-1
-2
Income Tax Expense
0
0
0
0
0
0
0
0
-
Net Income
0
0
0
1
0
0
-2
-1
-2
Net Profit Margin
73.19%
13.55%
44.02%
15.10%
16.42%
11.52%
13.61%
13.56%
14.62%

BioNexus Gene Lab Corp Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
0
0
-1
0
0
0
0
-1
0
0
Operating Cash Flow
0
0
-1
0
0
0
-1
0
0
0
Investing Cash Flow
0
0
0
0
0
0
0
0
0
0
Financing Cash Flow
0
0
0
0
0
0
0
0
0
0
Change in Cash
0
0
-1
0
0
0
0
1
0
-1

BioNexus Gene Lab Corp Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
0
0
0
1
0
0
-2
-1
-2
Operating Cash Flow
0
0
0
0
0
0
-1
-2
-1
Investing Cash Flow
-5
0
0
1
0
0
-1
0
0
Financing Cash Flow
5
0
0
0
0
0
6
0
0
Change in Cash
0
0
0
1
0
0
3
-1
0

Mutual Funds that own BioNexus Gene Lab Corp Stock

Check out the Mutual Funds with significant holdings in BioNexus Gene Lab Corp.

Funds
Holdings
Shares Held
Fidelity Concord Street Trust
0.080724%
2368

Global Institutional Holdings in BioNexus Gene Lab Corp

Funds
Holdings
UBS Group AG
0.01%
Wells Fargo & Co
0%
DRW Securities, LLC
0%

Insights on BioNexus Gene Lab Corp

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -1.03M → -286.45K (in $), with an average increase of 90.2% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 22.84K → 76.15K (in $), with an average increase of 70.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, NOVONESIS NOVOZYMES B American Depositary Receipts - Unsponsored Denmark has given 6.6% return, outperforming this stock by 77.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, NOVONESIS NOVOZYMES B American Depositary Receipts - Unsponsored Denmark has given 59.9% return, outperforming this stock by 143.7%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, BGLC stock has moved down by -39.8%

About BioNexus Gene Lab Corp

BioNexus Gene Lab Corp. (BGLC), established in 2017 and headquartered in Kuala Lumpur, Malaysia, conducts business through two primary subsidiaries. Its subsidiary, Chemrex Corporation Sdn. Bhd., specializes in the wholesale distribution of chemical raw material products across Malaysia, Indonesia, Vietnam, and other nations within Southeast Asia. These essential chemicals are utilized in the manufacturing of a wide array of products, including handrails, bench tops, components for the automotive and aerospace industries, cleanroom panels, and various instruments. Additionally, through its other subsidiary, BioNexus Gene Lab Sdn. Bhd., the company is involved in the development and provision of non-invasive liquid biopsy tests, designed for the early detection of biomarkers.
OrganisationBioNexus Gene Lab Corp
HeadquartersMenara UOA Bangsar, Kuala Lumpur, WP, 59000, MY
IndustryIndustrial - Distribution
CEOSu-Leng Tan
E-voting on sharesClick here to vote

Key Management of BioNexus Gene Lab Corp

Name

Title

Mr. Su-Leng Tan

CEO, President, Secretary & Director

Ms. Set Fui Chong

Chief Financial Officer

Mr. Kwan Wah Chan

Marketing Manager

Mr. Too Kam Tham

Managing Director

FAQs

What is BioNexus Gene Lab Corp share price today?

BioNexus Gene Lab Corp share price today is $1.50 as on at the close of the market. BioNexus Gene Lab Corp share today touched a day high of $1.53 and a low of $1.47.

What is the 52 week high and 52 week low for BioNexus Gene Lab Corp share?

BioNexus Gene Lab Corp share touched a 52 week high of $6.10 on and a 52 week low of $1.07 on . BioNexus Gene Lab Corp stock price today i.e. is closed at $1.50,which is 75.41% down from its 52 week high and 40.19% up from its 52 week low.

What is BioNexus Gene Lab Corp's market capitalisation today?

BioNexus Gene Lab Corp market capitalisation is $0.00T as on .

How to invest in BioNexus Gene Lab Corp Stock (BGLC) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for BioNexus Gene Lab Corp on INDmoney app. Click on Buy button. You can invest as low as $1.5 in BioNexus Gene Lab Corp Shares that will get you 1.0000 shares as per BioNexus Gene Lab Corp share price of $1.50 per share as on September 22, 2026 at 1:29 am IST.

What is the minimum amount required to buy BioNexus Gene Lab Corp Stock (BGLC) from India?

Indian investors can start investing in BioNexus Gene Lab Corp (BGLC) shares with as little as ₹95.805 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹958.05 in BioNexus Gene Lab Corp stock (as per the Rupee-Dollar exchange rate as on ). Based on BioNexus Gene Lab Corp share’s latest price of $1.50 as on September 22, 2026 at 1:29 am IST, you will get 6.6667 shares of BioNexus Gene Lab Corp. Learn more about fractional shares .